These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Clinical tests for antinuclear antibodies in diagnosis of collagen diseases]. Kubota T Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1921-5. PubMed ID: 14621580 [No Abstract] [Full Text] [Related]
8. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. Russell AS; Devani A; Maksymowych WP J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377 [TBL] [Abstract][Full Text] [Related]
9. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis? Zhao J; Liu X; Wang Z; Liu R; Li Z J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480 [TBL] [Abstract][Full Text] [Related]
10. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis. Jansen TL; Bruyn GA J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273 [No Abstract] [Full Text] [Related]
12. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
16. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? Bell DA J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974 [No Abstract] [Full Text] [Related]
17. [The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis]. Dijkmans BA; van Schaardenburg D; van der Horst-Bruinsma IE; Reesink HW; Vandenbroucke JP; Boers M Ned Tijdschr Geneeskd; 2005 Mar; 149(13):688-93. PubMed ID: 15819133 [TBL] [Abstract][Full Text] [Related]
18. Can anticyclic citrullinated peptide antibodies be used to successfully monitor treatment in rheumatoid arthritis patients? Vallbracht LL South Med J; 2006 Nov; 99(11):1197-8. PubMed ID: 17195406 [No Abstract] [Full Text] [Related]
19. Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist? Gao IK; Haas-Wöhrle A; Mueller KG; Lorenz HM; Fiehn C Ann Rheum Dis; 2005 Oct; 64(10):1516-7. PubMed ID: 16162906 [No Abstract] [Full Text] [Related]
20. [A new marker for the diagnosis of rheumatoid arthritis: cyclic citrullinated peptide antibodies (anti-CCP)]. Altindiş M Mikrobiyol Bul; 2003 Oct; 37(4):313-8. PubMed ID: 14748270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]